Subject	Predicate	Object
QKV8Ef5w	a	Resource
		Answer
		Written answer
	answer has question	LhLETlhl
	answer has answering person	James O'Shaughnessy
	answer text	<p>Orkambi does not have a marketing authorisation in the United Kingdom for use in the treatment of children aged under 12 with cystic fibrosis. Where clinically appropriate and subject to the relevant commissioner making funding available, Orkambi may be prescribed as an off-label drug. Off-label prescribing is supported in guidance given to prescribers by both the General Medical Council and by the Medicines and Healthcare products Regulatory Agency.</p>
	answer given date	2017-07-11
	answer has answering body	Department of Health
	written answer has answering body	Department of Health
Department of Health	answering body has written answer	QKV8Ef5w
Department of Health	answering body has answer	QKV8Ef5w
LhLETlhl	question has answer	QKV8Ef5w
James O'Shaughnessy	answering person has answer	QKV8Ef5w